P3I
PFE icon

Progeny 3 Inc’s Pfizer PFE Stock Holding History

Progeny 3 Inc’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-44,943
Closed -$1.37M – 24
2014
Q1 		$1.37M Buy
44,943
+16,685
+59% +$497K 1.25% 16
2013
Q4 		$821K Sell
28,258
-44,131
-61% -$1.28M 0.89% 21
2013
Q3 		$770K Hold
72,389
– – 0.5% 24
2013
Q2 		$1.92M Buy
+72,389
New +$2M 1.14% 16

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Progeny 3 Inc's PFE Position: Q2 2014 in Review

Progeny 3 Inc sold out of Pfizer (PFE) in Q2 2014, closing a stake of 44,943 shares — an estimated $1.37M sold.

Progeny 3 Inc first reported a position in PFE in Q2 2013 and held it in 4 quarters. The position peaked at $1.92M in Q2 2013. 1,745 funds tracked by Wall St. Rank hold PFE as of Q2 2014.

  • Progeny 3 Inc reported no remaining Pfizer position as of Q2 2014 after selling out during the quarter.
  • Progeny 3 Inc sold 44,943 Pfizer shares in Q2 2014, an estimated $1.37M.
  • Progeny 3 Inc first reported a position in Pfizer in Q2 2013 and held it in 4 quarters.
  • Progeny 3 Inc's Pfizer position peaked at $1.92M in Q2 2013.
  • 1,745 funds tracked by Wall St. Rank held Pfizer as of Q2 2014.

Based on Progeny 3 Inc's 13F filing for Q2 2014, filed 14 Aug 2014.